- Chelsea Therapeutics (NASDAQ:CHTP) is halted; multiple sources say Northera was approved by the FDA, but there's still no official press release from the FDA or the company.
- A decision for the Northera new drug application was postponed from last Friday due to an office closure caused by severe weather.
Chelsea's Northera NDA reportedly approved, shares halted
Recommended For You
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
CHTP | - | - |
Chelsea Therapeutics International, Ltd. |